WAKAMOTO PHARMACEUTICAL CO.,LTD.
4512 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町二丁目２番２号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Wakamoto Pharmaceutical Co., Ltd. is a leading Japanese company dedicated to promoting health and wellness through its range of innovative healthcare products. Specializing in both over-the-counter (OTC) and prescription medications, Wakamoto emphasizes the importance of healthy families and communities. With a commitment to quality and effectiveness, the company aims to provide solutions that ensure individuals and families remain cheerful and healthy. Leveraging years of expertise, Wakamoto continues to develop products that meet the evolving needs of consumers, reinforcing its reputation as a trusted name in the pharmaceutical industry.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 10:03 |
Inside Information Statement
臨時報告書
|
Japanese | 24.7 KB | |
| 2025-06-20 08:53 |
Internal Control over Financial Reporting
内部統制報告書－第130期(2024/04/01－2025/03/31)
|
Japanese | 21.5 KB | |
| 2025-06-20 08:51 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-20 08:48 |
Annual Report
有価証券報告書－第130期(2024/04/01－2025/03/31)
|
Japanese | 1014.1 KB | |
| 2025-02-06 08:28 |
Inside Information Statement
臨時報告書
|
Japanese | 19.3 KB | |
| 2024-11-13 01:51 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-11-13 01:46 |
Interim Report
半期報告書－第130期(2024/04/01－2025/03/31)
|
Japanese | 183.5 KB | |
| 2024-07-02 05:00 |
Inside Information Statement
臨時報告書
|
Japanese | 33.6 KB | |
| 2024-06-28 08:24 |
Internal Control over Financial Reporting
内部統制報告書－第129期(2023/04/01－2024/03/31)
|
Japanese | 21.7 KB | |
| 2024-06-28 08:21 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-28 08:19 |
Annual Report
有価証券報告書－第129期(2023/04/01－2024/03/31)
|
Japanese | 1007.9 KB | |
| 2024-02-14 01:17 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-02-14 01:17 |
Quarterly Report
四半期報告書－第129期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 155.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
| BrightPath Biotherapeutics Co., Ltd. | Japan | 4594 | ||
|
Calliditas Therapeutics | Sweden | CALTX | |
|
Camurus | Sweden | CAMX | |
| CanBas Co.,Ltd. | Japan | 4575 | ||
|
Cannabotech Ltd. | Israel | CNTC |